Lower doses of the malaria drug primaquine were found to work as well as the standard dose, according to a study in The Lancet Infectious Diseases. Researchers said the lower dose might prevent cases of reduced blood count, a side effect in patients with G6PD enzyme deficiency.

Full Story:
Medical News Today

Related Summaries